Evidence map›Paper›PMID 30136180›Full record

ArticleVirchows Archiv : an international journal of pathology2018

Local vs. systemic pulmonary amyloidosis-impact on diagnostics and clinical management.

Julius-Valentin Baumgart, Christiane Stuhlmann-Laeisz, Ute Hegenbart, Johanna Nattenmüller, Stefan Schönland, Sandra Krüger, Hans-Michael Behrens, Christoph Röcken

Open access · hybridAbstract readComparative Study
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. A rare presentation of pulmonary transthyretin amyloidosis.Respiratory medicine case reports · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Emerald Sign for Diagnosing Tracheobronchial Amyloidosis.Internal medicine (Tokyo, Japan) · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Julius-Valentin BaumgartDepartment of Pathology, Christian-Albrechts-University, Arnold-Heller-Str. 3/14, D-24105, Kiel, Germany.
Christiane Stuhlmann-LaeiszDepartment of Pathology, Christian-Albrechts-University, Arnold-Heller-Str. 3/14, D-24105, Kiel, Germany.
Ute HegenbartMedical Department V, Amyloidosis Center, University of Heidelberg, Heidelberg, Germany.
Johanna NattenmüllerMedical Department V, Amyloidosis Center, University of Heidelberg, Heidelberg, Germany.
Stefan SchönlandMedical Department V, Amyloidosis Center, University of Heidelberg, Heidelberg, Germany.
Sandra KrügerDepartment of Pathology, Christian-Albrechts-University, Arnold-Heller-Str. 3/14, D-24105, Kiel, Germany.
Hans-Michael BehrensDepartment of Pathology, Christian-Albrechts-University, Arnold-Heller-Str. 3/14, D-24105, Kiel, Germany.
Christoph RöckenDepartment of Pathology, Christian-Albrechts-University, Arnold-Heller-Str. 3/14, D-24105, Kiel, Germany. christoph.roecken@uksh.de.ORCID http://orcid.org/0000-0002-6989-8002
Christian-Albrechts-Universität zu Kiel · DEHeidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunoglobulin-derived light-chain (AL) amyloidosis of lungs and bronchi can appear as a systemic and a local form. While systemic AL amyloidosis may need haemato-oncological care, the localised form can be treated restrained. We re-evaluated 207 specimens of lungs and bronchi sent in for amyloid diagnostics. Amyloid was diagnosed by polarization microscopy using Congo red-stained tissue specimens and classified immunohistochemically. Histoanatomical amyloid distribution patterns were documented as well as additional histological findings. For 118 patients with AL amyloidosis, we retrieved clinical data. CT scan results were available from 59 patients. AL amyloidosis was the most common type (183 cases). ALλ was found in 141 and of ALκ in 27 cases. Fifteen cases were AL amyloid not otherwise specified. Twenty cases harboured transthyretin and three serum amyloid A derived amyloid. By correlation of histoanatomy, radiological and clinical data, amyloid was rarely in the initial differential diagnosis. Local AL amyloidosis often presented with a nodular pattern on CT scan and showed a significantly better disease-specific 10-year survival compared with systemic AL amyloidosis (96.0 vs. 51.9%). Localised and systemic pulmonary and bronchial AL amyloidosis are having a completely different prognosis. While CT scan might be indicative, histological and clinical assessment are mandatory to reach a proper diagnosis and guide patient care.

Indexed as

AdultAgedAged, 80 and overDiagnosis, DifferentialFemaleFollow-Up StudiesHumansImmunoglobulin Light-chain AmyloidosisImmunohistochemistryLungMaleMiddle AgedRetrospective StudiesSurvival RateTreatment OutcomeAmyloidImmunoglobulinLight chainTransthyretin

Identifiers

PMID30136180
OpenAlexW2888311116

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.